Arena's (ARNA) Lorcaserin Becomes First Weight-Loss Drug Approved in 13 Years
Tweet Send to a Friend
Up)
With approval, Arena Pharmaceuticals' (Nasdaq: ARNA) lorcaserin (Belviq) becomes first weight-loss drug approved in 13 years. Shares are currently halted.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Tesla (TSLA) Ramps Higher (GM)
- Monster (MNST) on Watch; AMA Calls for Ban on Advertising Energy Drinks to Kids
- Icahn Proposes Dell (DELL) Start Offer for 1.1B Shares at $14/Share
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
